Glimpses 2009-2010.pdf - LV Prasad Eye Institute

Name of the Project
A randomised double-masked active controlled phase 3 study of
the efficacy, safety and tolerability of repeated doses of intravitreal
VEGF trap-eye in subjects with neovascular age related macular
degeneration (AMD) VEGF TRAP study
The treatment of fungal corneal ulcer with Povidone - Iodine 1.25%
ophthalmic solution. A comparative clinical trial
Comparative, randomized, open trial on the anti-inflammatory
efficacy of diclofenac released from an intra ocular lens versus
administration of 0.1% diclofenac eye-drops in the prevention of
post operative inflammatory manifestations after cataract surgery. –
Ancillary study: 1 year follow-up of the safety
A retrospective analysis of long-term outcome of primary angle
closure glaucoma patients treated with peripheral iridotomy
Micro current stimulation for retinitis pigmentosa 650 device pilot
study
A phase 2/3 randomised, controlled double-masked multi-center
comparitive trial in parallel groups to compare the safety and
efficacy of intravitreous injections of 0.3 mg pegaptanib sodium
(Macugen) given as often as every 6 weeks for 2 years, to sham
injections in subjects with Diabetic Macular Edema (DME) involving
the center of the macula
A multi-center, placebo-controlled, randomized, parallel group
dose-ranging study to assess the efficacy and safety of LX201 for
prevention of corneal allograft rejection episodes and graft failure
following penetrating keratoplasty with LX201 implantation in
subjects who are at increased immunological risk.
A multi-center, placebo-controlled, randomized, parallel group
dose-ranging study to assess the efficacy and safety of LX201 for
prevention of corneal allograft rejection episodes and graft failure
following penetrating keratoplasty with LX201 implantation in
subjects who have experienced one or more rejection episodes
following penetrating keratoplasty
Protein Kinase C ß Inhibitor -- reduction in the occurrence of
center-threatening diabetic macular edema. B7A-MC-MBDL
Clinical research projects
Project
Investigators
Dr Raja Narayanan
Dr Prashant Garg
Dr Savitri Sharma
Dr Virender S Sangwan
Supported by
Bayer HealthCare,
Germany
University of California,
Los Angeles, USA
IOL Tech Carl Zeiss
MediTec, France
2008-2011
Dr Sirisha Senthil Pfizer, USA 2009-2011
Dr Subhadra Jalali ScyFix, USA 2007-2010
Dr Subhadra Jalali Pfizer, USA 2006-2012
Dr Virender S Sangwan LUX Biosciences, USA 2008-2010
Dr Virender S Sangwan LUX Biosciences, USA 2008-2010
Dr Subhadra Jalali Eli Lily, India 2005-2010
Duration
2008 onwards (Hyderabad and
Bhubaneswar campuses)
2006-2011
Posurdex study for DME Dr Ajit Babu Majji Allergan, USA 2006-2009
Posurdex study for RVO Dr Annie Mathai Allergan, USA 2006-2009
Posurdex study for intermediate uveitis Dr Virender S Sangwan Allergan, USA 2006-2009
LUMINATE uveitis study (LX211-01-UV)
Dr Somasheila Murthy
Dr Soumyava Basu
LUX Biosciences, USA 2007-2009 (Hyderabad and
Bhubaneswar campuses)
LUMINATE uveitis study (LX211-02-UV)
LUMINATE uveitis study (LX211-03-UV)
A phase 3 safety and efficacy study of vitreosolve for ophthalmic
intravitreal injection for inducing posterior vitreous detachment in
retinopathy subjects
Comparison of postoperative refractive outcomes after calculation
of IOL power using the IOL master and ultrasound biometry
A phase II prospective, randomised, multi-center, diabetic vascular
edema dose ranging, comparator study evaluating the efficacy and
safety of PF-04523655 versus laser therapy (DEGAS)
A 6-day, phase 3, multicenter, randomised, double-masked, parallel
study to compare the safety and efficacy of Gatifloxacin 0.5%
ophthalmic solution BD with that of vehicle in the treatment of
acute bacterial conjunctivitis
A study of unilateral retinoblastoma with and without
histopathologic high-risk features and the role of adjuvant
chemotherapy – a groupwide phase III study
A phase 3 prospective, randomized, double-masked, 12-week
parallel group study evaluating the efficacy and safety of Latanoprost
and Timolol in paediatric subjects with glaucoma
Indian Council of Medical Research National Retinoblastoma
Registry
Dr Somasheila Murthy
Dr Soumyava Basu
Dr Somasheila Murthy
Dr Soumyava Basu
Dr Ajit Babu Majji
Dr Taraprasad Das
LUX Biosciences, USA
LUX Biosciences, USA
Vitreo Retinal Agencies,
USA
2007-2009 (Hyderabad and
Bhubaneswar campuses)
2007-2009 (Hyderabad and
Bhubaneswar campuses)
2008-2010 (Hyderabad and
Bhubaneswar campuses)
Dr Sujata Das Hyderabad Eye
Research Foundation,
India
2009 onwards
Dr Soumyava Basu Pfizer, USA 2009 onwards
Dr Prashant Garg Allergan, USA 2008-2009
Dr Santosh G Honavar National Childhood
Cancer Foundation,
USA
2009-2011
Dr Anil K Mandal Pfizer, USA 2009 (3 months study)
Dr Santosh G Honavar
Dr P M Fairooz
Indian Council of
Medical Research, India
2009 onwards
Excellence Equity Efficiency Page
40
F_Inside_Pgs.indd 40
9/2/2010 12:33:20 PM